Welcome to LookChem.com Sign In|Join Free

CAS

  • or

146621-89-8

Post Buying Request

146621-89-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

146621-89-8 Usage

Description

((R)-benzyloxycarbonylmethylamino)phenylacetic acid is a phenylacetic acid derivative featuring an additional benzyl group and a carbonyl group attached to a methylamino group. ((R)-benzyloxycarbonylmethylamino)phenylacetic acid is recognized for its role as a reagent in organic synthesis and as a building block in the creation of pharmaceuticals and bioactive compounds. Its unique chemical structure and properties render it advantageous for peptide bond formation and protein modification, positioning it as a promising candidate for drug development and biotechnological applications.

Uses

Used in Pharmaceutical and Bioactive Compound Synthesis:
((R)-benzyloxycarbonylmethylamino)phenylacetic acid is utilized as a key building block for the synthesis of various pharmaceuticals and bioactive compounds. Its ability to form peptide bonds and modify proteins makes it instrumental in the development of new drugs and therapeutic agents.
Used in Drug Development:
In the field of drug development, ((R)-benzyloxycarbonylmethylamino)phenylacetic acid is employed as a reagent to facilitate the creation of novel drug candidates. Its interaction with biological molecules and its potential to enhance the properties of existing drugs contribute to its value in this industry.
Used in Biotechnology:
((R)-benzyloxycarbonylmethylamino)phenylacetic acid is used as a versatile tool in biotechnology for research and development. Its capacity to engage with biological systems and contribute to the modification of proteins provides a foundation for innovative applications in this sector.
Used in Organic Synthesis:
As a reagent in organic synthesis, ((R)-benzyloxycarbonylmethylamino)phenylacetic acid is applied to construct complex organic molecules and compounds. Its structural features and reactivity make it a valuable component in the synthesis of a wide range of organic compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 146621-89-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,6,6,2 and 1 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 146621-89:
(8*1)+(7*4)+(6*6)+(5*6)+(4*2)+(3*1)+(2*8)+(1*9)=138
138 % 10 = 8
So 146621-89-8 is a valid CAS Registry Number.

146621-89-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name ((R)-benzyloxycarbonylmethylamino)phenylacetic acid

1.2 Other means of identification

Product number -
Other names (R)-(Benzyloxycarbonyl-methyl-amino)-phenyl-acetic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:146621-89-8 SDS

146621-89-8Downstream Products

146621-89-8Relevant articles and documents

Backbone modifications in peptidic inhibitors of flaviviral proteases

Jakob, Alexander K.M.H.,Sundermann, Tom R.,Klein, Christian D.

supporting information, p. 1913 - 1917 (2019/06/08)

The NS2B-NS3 protease is a promising target for the development of drugs against dengue virus (DENV), West Nile virus (WNV) and related flaviviruses. We report the systematic variation of the peptide backbone of the two lead compounds Bz-Arg-Lys-D-Phg-NH

AMINO-SUBSTITUTED ETHYLAMINO Beta2 ADRENERGIC RECEPTOR AGONISTS

-

Page/Page column 55, (2008/06/13)

The invention provides novel beta2 adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with beta2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 146621-89-8